Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

March 31, 2009

Caltech researcher helps develop technique that homes in on aggressive, difficult-to-treat HER2+ breast cancer cells

PASADENA, Calif.--Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.




A paper describing their work is highlighted in this week's issue of the online edition of the Proceedings of the National Academy of Sciences (PNAS).

Corroles have very similar structures to the porphyrin molecules used in a well-studied cancer treatment known as photodynamic therapy, or PDT, in which porphyrin compounds injected into the body are exposed to specific wavelengths of laser light. The light prompts the porphyrins to produce active, tumor-killing oxygen radicals.

The difference between porphyrins and corroles, says Harry Gray, Caltech's Arnold O. Beckman Professor of Chemistry and founding director of the Beckman Institute, is that some corroles don't require a laser boost to turn lethal. "The striking thing about gallium corroles is that they apparently kill cancer cells in the dark," says Gray. "We don't yet know exactly how this works, but what we've seen so far tells us that it does work."

He notes that "ongoing work in our laboratories focuses on testing our leading hypotheses for elucidating the mechanism of action."

In the experiments described in the PNAS paper, the team paired a gallium corrole with a carrier protein, then aimed it at cells that carry the human epidermal growth factor receptor 2 (HER2). The presence of a HER2 receptor is the hallmark of about 25 percent of breast cancers, and marks those tumors as particularly aggressive and difficult to treat.

In trials in mice, the targeted corrole was able to shrink tumors at doses five times lower than that of the standard chemotherapeutic agent for HER2-positive tumors, a drug called doxorubicin. In contrast with doxorubicin, the corrole was injected into the bloodstream, rather than directly into the tumor.

"We looked at three groups of mice with human tumors," explains paper coauthor Lali Medina-Kauwe, an assistant professor of medicine at the David Geffen School of Medicine at UCLA, and a faculty research scientist in the Department of Biomedical Science at Cedars-Sinai Medical Center in Los Angeles. "In one, we introduced just the protein carrier, without the corrole; tumor growth in those mice did not change. In other mice, we gave the corrole without the carrier protein; this led to some tumor suppression. But it was the last group, the ones that got the corrole with the carrier protein, that experienced the most therapeutic effect."

"The fact that we can target this compound means we can give it at very low concentrations," adds coauthor Daniel Farkas, director of Cedar-Sinai's Minimally Invasive Surgical Technologies Institute. "Using lower concentrations means less toxicity. Doxorubicin tends to have significant heart toxicity; this therapy seems likely to be much less damaging to the heart."

In addition, adds Medina-Kauwe, targeted compounds can seek out tumors wherever they may be. "One of the beauties of targeting," she says, " is that we can go after metastatic tumors that are too small to be seen."

These targeted gallium corroles are not only effective, they're also easy to study, notes Zeev Gross, the Reba May & Robert D. Blum Academic Chair at Technion, the Israeli Institute of Technology, in Haifa, and another of the paper's coauthors. "In most cases, if people want to get a closer look at a drug in vivo, they have to attach a fluorescent probe to it--and that turns it into a different molecule. But in our case, the active molecule we're tracking does the fluorescing. We get to track the original, unmodified molecule and are hence able to follow its distribution among different organs in live animals."

The difficulty in getting to this point, notes Gray, is that corroles have been challenging to synthesize. "Then Zeev came up with a powerful synthetic method to make corroles," he says. "We went from being able to make a couple of milligrams in two years to being able to make two grams in two days. It really puts corroles on the map."

Gray and Gross further add, "It is truly fulfilling to see how the close collaboration between our research groups at Caltech and the Technion, which started 10 years ago with a focus on developing the fundamental science of corroles, led to pharmaceutical utility when we joined forces with Medina-Kauwe and Farkas, who are experts in cellular biology and biomedical imaging technologies."

California Institute of Technology



Related Breast Cancer Tumors Current Events and Breast Cancer Tumors News Articles Breast Cancer Tumors Current Events and Breast Cancer Tumors News RSS Breast Cancer Tumors Current Events and Breast Cancer Tumors News RSS
Study shows PET can measure effectiveness of novel breast cancer treatment
A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

I-SPY trial offers key insights into locally advanced breast cancer
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease.

UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
New research from UC Davis Cancer Center shows that a protein called Muc4 may be the essential ingredient that allows breast cancer to spread to other organs and resist therapeutic treatment.

Research shows biopsy of recurrent breast cancer can alter treatment
For women with recurrent breast cancer, the treatment the doctor chooses is usually based on the properties of their original breast cancer. A group from Toronto has recently completed the world's first study that compared original breast cancer tumors with a biopsy of suspected tumors that recurred elsewhere in the body.

New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
Chemotherapy is an integral part of modern cancer treatment, but it's not always effective. Successful chemotherapy depends on the ability of anticancer drugs to escape from the bloodstream through the leaky blood vessels that often surround tumors.

2 new compounds show promise for eliminating breast cancer tumors
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.

The dietary supplement genistein can undermine breast cancer treatment
Women taking aromatase inhibitors to treat breast cancer or prevent its recurrence should think twice before also taking a soy-based dietary supplement, researchers report.

Ability to track stem cells in tumors could advance cancer treatments
Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms.

OHSU Cancer Instutute researchers find abnormalities in gene for melanoma
New research from the Oregon Health & Science University Cancer Institute about mutations in melanoma may bring a wellspring of hope to many patients.

OHSU Cancer Institute researchers find connection between protein, prognosis in breast cancer
Oregon Health & Science University Cancer Institute researchers have found that a tumor protein present in an aggressive form of breast cancer is related to a poor prognosis.
More Breast Cancer Tumors Current Events and Breast Cancer Tumors News Articles
  Fusion of FNA-cytology and gene-expression data using Dempster-Shafer theory of evidence to predict breast cancer tumors.(Hypothesis): An article from: Bioinformation
by Mansoor Raza (Author), Iqbal Gondal (Author), David Green (Author), Ross L. Coppel (Author)

This digital document is an article from Bioinformation, published by Thomson Gale on January 1, 2006. The length of the article is 3652 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Fusion of FNA-cytology and gene-expression data using Dempster-Shafer theory of evidence to predict breast cancer tumors.(Hypothesis)
Author: Mansoor Raza
Publication: Bioinformation (Magazine/Journal)
Date: January 1, 2006
Publisher: Thomson Gale
Page: 170(6)

Distributed by Thomson...

American Cancer Society Film: Time is Life (1949) [DVD]

American Cancer Society Film: Time is Life (1949) [DVD]

Time is Life highlights the importance of time in combating the second highest cause of death in the world, cancer. The film also underscores the efforts of the American Cancer Society towards the alleviation, if not elimination, of cancer in the American society. The film starts with Mary Bronson being stressed out with the possibility of having a cancer. Cancer is not given proper attention by the public so it causes insurmountable effects on people in the society. Cancer chooses no one. In addition, the film gives conveying figures on cancer fatalities in the United States saying that one in every eight American has cancer. The film has also mentioned that cancer has killed more Americans than the slaughter at the Pearl Harbor and Tokyo Bay during World War Two. The film also dispels...

Breast Health, Maximum International, 60 Capsules, 6 Bottles

Breast Health, Maximum International, 60 Capsules, 6 Bottles
by Maximum International

Breast Health is a multi-ingredient blend of natural ingredients formulated to maintain healthy breast tissue. The nutrients found in Breast Health have been carefully selected based upon the most current research on natural hormone balance, systemic detoxification, and enhancing immune function. The ingredients in Breast Health include: Plant-Based Estrogens: Estrogen plays a pivotal role in the health of the breast, and in particular, in the development of breast cancer. Breast Health contains a complex of beneficial estrogenic plant extracts which compete with toxic or harmful estrogen and help to balance the female hormone system. Anti-Tumor/Anti-Fibroid Compounds: The body relies on natural processes to break down and remove scarred tissue, fibrous masses, and tumorous growths...

Cancer Be Gone

Cancer Be Gone

Guided imagery CD taps into the immense power of the mind to enhance comfort, healing, an optimistic attitude and positive expectations. Metaphor of "cancer as weeds in a garden that are easily managed".

Visualizing Early-Stage Breast Cancer Tumors in a Mammographic Environment Through a 3-Dimensional Mathematical Model

Visualizing Early-Stage Breast Cancer Tumors in a Mammographic Environment Through a 3-Dimensional Mathematical Model
by Christopher B. Bassham (Author)

This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH SCHOOL OF ENGINEERING report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A936163. The abstract provided by the Pentagon follows: In response to the insidious and deadly nature of breast cancer and the less-than-perfect detection ability of mammography, we develop a mathematical model as a foundation to the long-term goal of improving early breast cancer detection. By using modeling and simulation to construct an accurate breast cancer tumor model, we hope to solve the problems associated with mammogram misdiagnosis and,...

An Object-Oriented Approach to the Modeling and Visualization of Early- Stage Breast Cancer Tumors

An Object-Oriented Approach to the Modeling and Visualization of Early- Stage Breast Cancer Tumors
by Bruce C. Jenkins (Author)

This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH SCHOOL OF ENGINEERING report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A242873. The abstract provided by the Pentagon follows: Great strides have been made in controlling the progression of breast cancer, but medical professionals continue to rely primarily upon traditional mammography for early detection. Enhancing breast cancer detection capabilities - and thus reducing tumor detection time - should result in a reduction in mortality rates. The detection capabilities of mammography may be enhanced through improved...

  History of HRT use benefits breast cancer patients. (Tumor Growth Reduced in Bone).(hormone replacement therapy): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2003. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: History of HRT use benefits breast cancer patients. (Tumor Growth Reduced in Bone).(hormone replacement therapy)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: March 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 5 Page: 49(1)

Distributed by Thomson...

  Bionomic's gene silencing molecules inhibitor tumor growth in breast cancer model.: An article from: BIOTECH Patent News
by Biotech Patent News (Publisher)

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on November 1, 2004. The length of the article is 418 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Bionomic's gene silencing molecules inhibitor tumor growth in breast cancer model.
Publication: BIOTECH Patent News (Newsletter)
Date: November 1, 2004
Publisher: Biotech Patent News
Volume: 18 Issue: 11

Distributed by Thomson Gale

  Raising Health Awareness Through Examining Benign Brain Tumor Cancer, Alpha One, and Breast Implant Issues: Hearing Before the Committee on Energy and Commerce, U.S. House of Representatives
by Michael Bilirakis (Editor)



  A comparative study of four serological tumor markers for the detection of breast cancer.: An article from: Journal of the Mississippi Academy of Sciences
by Shawn R. Clinton (Author), Kevin L. Beason (Author), Sabrina Bryant (Author), James T. Johnson (Author), Margaret Jackson (Author), Cynthia Wilson (Author), Kay Holifield (Author), Charlton Vincent (Author), Margot Hall (Author)

This digital document is an article from Journal of the Mississippi Academy of Sciences, published by Mississippi Academy of Sciences on April 1, 2002. The length of the article is 4301 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: A comparative study of four serological tumor markers for the detection of breast cancer.
Author: Shawn R. Clinton
Publication: Journal of the Mississippi Academy of Sciences (Magazine/Journal)
Date: April 1, 2002
Publisher: Mississippi Academy of Sciences
Volume: 47 Issue: 2 Page: 124(7)

Distributed by Thomson...

© 2009 BrightSurf.com